Cancer Biotherapy & Radiopharmaceuticals, 1557-8852

Journal

More filtering options
  1. 2018
  2. Simultaneous Preclinical Positron Emission Tomography-Magnetic Resonance Imaging Study of Lymphatic Drainage of Chelator-Free Cu-Labeled Nanoparticles

    Renata Madru, Budassi, M., Benveniste, H., Lee, H., Smith, S. D., Schlyer, D. J., Vaska, P., Linda Knutsson & Sven-Erik Strand, 2018 Aug, In : Cancer Biotherapy & Radiopharmaceuticals. 33, 6, p. 213-220 8 p.

    Research output: Contribution to journalArticle

  3. 2015
  4. Cancer Cell Radiobiological Studies Using In-House-Developed α-Particle Irradiator.

    Nilsson, J., Bauden, M., Nilsson, J., Sven-Erik Strand & Elgqvist, J., 2015, In : Cancer Biotherapy & Radiopharmaceuticals. 30, 9, p. 386-394

    Research output: Contribution to journalArticle

  5. 2014
  6. Sequential Radioimmunotherapy with (177)Lu- and (211)At-Labeled Monoclonal Antibody BR96 in a Syngeneic Rat Colon Carcinoma Model.

    Sophie Eriksson, Elgström, E., Bäck, T., Ohlsson, T. G., Jensen, H., Rune Nilsson, Lindegren, S. & Jan Tennvall, 2014, In : Cancer Biotherapy & Radiopharmaceuticals. 29, 6, p. 238-246

    Research output: Contribution to journalArticle

  7. 2012
  8. 2009
  9. Early changes in 2-deoxy-2-[18F]fluoro-D-glucose metabolism in squamous-cell carcinoma during chemotherapy in vivo and in vitro.

    Bjurberg, M., Henriksson, E., Eva Brun, Lars Ekblad, Ohlsson, T. G., Arne Brun & Kjellén, E., 2009, In : Cancer Biotherapy & Radiopharmaceuticals. 24, 3, p. 327-332

    Research output: Contribution to journalArticle

  10. Glomerular Filtration Rate After Alpha-Radioimmunotherapy with At-211-MX35-F(ab ')(2): A Long-Term Study of Renal Function in Nude Mice

    Back, T., Haraldsson, B., Hultborn, R., Jensen, H., Martin Johansson, Lindegren, S. & Jacobsson, L., 2009, In : Cancer Biotherapy & Radiopharmaceuticals. 24, 6, p. 649-658

    Research output: Contribution to journalArticle

  11. 2008
  12. Evaluation of toxicity-reducing potential of ECAT in combination with drug-conjugated mAb BR96

    Mårtensson, L., Rune Nilsson, Hans Olov Sjögren & Jan Tennvall, 2008, In : Cancer Biotherapy and Radiopharmaceuticals. 23, 4, p. 520-520

    Research output: Contribution to journalPublished meeting abstract

  13. Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by radiometal-labeled monoclonal antibodies.

    Nemecek, ER., Green, DJ., Fischer, DR., Pagel, JM., Lin, Y., Gopal, AK., Durack, LD., Rajendran, JG., Wilbur, DS., Rune Nilsson, Sandberg, B. & Press, OW., 2008, In : Cancer Biotherapy & Radiopharmaceuticals. 23, 2, p. 181-191

    Research output: Contribution to journalArticle

  14. Peptide receptor radionuclide therapy (PRRT) using Lu-177-Dotatate: Early clinical and dosimetric results

    Garkavij, M., Katarina Sjögreen Gleisner, Nickel, M., Ohlsson, T. G., Wingårdh, K. & Jan Tennvall, 2008, In : Cancer Biotherapy and Radiopharmaceuticals. 23, 4, p. 524-525

    Research output: Contribution to journalPublished meeting abstract

  15. Quantitative serial imaging of an I-124 anti-CEA monoclonal antibody in tumor-bearing mice

    Bading, J. R., Horling, M., Williams, L. E., Colcher, D., Raubitschek, A. & Sven-Erik Strand, 2008, In : Cancer Biotherapy & Radiopharmaceuticals. 23, 4, p. 399-409

    Research output: Contribution to journalArticle

  16. 2007
  17. Optimization of energy-window settings for scatter correction in quantitative In-111 imaging: Comparison of measurements and Monte Carlo simulations

    Holstensson, M., Hindorf, C., Michael Ljungberg, Partridge, M. & Flux, G. D., 2007, In : Cancer Biotherapy & Radiopharmaceuticals. 22, 1, p. 136-142

    Research output: Contribution to journalArticle

  18. Single-cell dosimetry for radioimmunotherapy of B-cell lymphoma patients with special reference to leukemic spread

    Hindorf, C., Emfietzoglou, D., Lindén, O., Bousis, C., Fotopoulos, A., Kostarelos, K. & Flux, G. D., 2007, In : Cancer Biotherapy & Radiopharmaceuticals. 22, 3, p. 357-366

    Research output: Contribution to journalArticle

  19. 2006
  20. Comparative renal, hepatic, and bone marrow toxicity of Cisplatin and radioactive Cisplatin ((191)pt) in wistar rats.

    Norrgren, K., Sjölin, M., Bjorkman, S., Areberg, J., Anders Johnsson, Johansson, L. & Sören Mattsson, 2006, In : Cancer Biotherapy & Radiopharmaceuticals. 21, 5, p. 528-534

    Research output: Contribution to journalArticle

  21. 2005
  22. A novel platform for radioimmunotherapy: extracorporeal depletion of biotinylated and (90)y-labeled rituximab in patients with refractory B-cell lymphoma.

    Lindén, O., Kurkus, J., Garkavij, M., Cavallin-Ståhl, E., Michael Ljungberg, Rune Nilsson, Ohlsson, T. G., Sandberg, B., Sven-Erik Strand & Jan Tennvall, 2005, In : Cancer Biotherapy & Radiopharmaceuticals. 20, 4, p. 457-466

    Research output: Contribution to journalArticle

  23. Internal microdosimetry for single cells in radioimmunotherapy of B-cell lymphoma.

    Hindorf, C., Emfietzoglou, D., Lindén, O., Kostarelos, K. & Sven-Erik Strand, 2005, In : Cancer Biotherapy & Radiopharmaceuticals. 20, 2, p. 224-230

    Research output: Contribution to journalArticle

  24. Population biokinetic modeling of thyroid uptake and retention of radioiodine.

    Areberg, J., Jönsson, H. & Sören Mattsson, 2005, In : Cancer Biotherapy & Radiopharmaceuticals. 20, 1, p. 1-10

    Research output: Contribution to journalArticle

  25. 2004
  26. Blood pharmacokinetics of various mabs labeled with a new tri-chelating reagent for simultaneous conjugation with DOTA and biotin prior to radiolabeling

    Wang, Z., Mårtensson, L., Rune Nilsson, Pär-Ola Bendahl, Lindgren, L., Ohlsson, T. G., Sjögren, H. O., Sven-Erik Strand & Jan Tennvall, 2004, In : Cancer Biotherapy and Radiopharmaceuticals. 19, 4, p. 540-541

    Research output: Contribution to journalPublished meeting abstract

  27. 2003
  28. Accuracy of the quantification of organ activity from planar gamma camera images

    Norrgren, K., Svegborn, SL., Areberg, J. & Sören Mattsson, 2003, In : Cancer Biotherapy & Radiopharmaceuticals. 18, 1, p. 125-131

    Research output: Contribution to journalArticle

  29. Biokinetics of iodide in man: Refinement of current ICRP dosimetry models

    Johansson, L., Sigrid Leide Svegborn, Sören Mattsson & Nosslin, B., 2003, In : Cancer Biotherapy & Radiopharmaceuticals. 18, 3, p. 445-450

    Research output: Contribution to journalArticle

  30. Calibration of a radioactive ink-based stack phantom and its applications in nuclear medicine.

    El-Ali, H., Michael Ljungberg, Sven-Erik Strand, Palmer, J., Malmgren, L. & Nilsson, J., 2003, In : Cancer Biotherapy & Radiopharmaceuticals. 18, 2, p. 201-207

    Research output: Contribution to journalArticle

  31. 1994
  32. Extracorporeal immunoadsorption of 125I-labeled monoclonal antibody L6.

    Norrgren, K., Garkavij, M., Lars, L., Rune Nilsson, Sven-Erik Strand, Jan Tennvall & Hans Olov Sjögren, 1994, In : Antibody, immunoconjugates, and radiopharmaceuticals. 7, p. 29-42

    Research output: Contribution to journalArticle

  33. 1991